Largest pharmaceuticals by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Definium Therapeutics has the lowest figure of the 35 pharmaceuticals ranked by total debt, at TRY 2B, followed by Rhythm Pharmaceuticals (TRY 5.5B) and Axsome Therapeutics (TRY 9.5B). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- Lowest
- Definium TherapeuticsTRY 2B
- Median
- TRY 266B
- Combined market value
- TRY 256.25T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Definium TherapeuticsDFTX · Health Care | TRY 2B | TRY 196.7B | TRY 1,436.62 | 3.05% down | 169% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 5.5B | TRY 408.1B | TRY 5,885.69 | 0.08% up | 13% up | ||
| 3 | Axsome TherapeuticsAXSM · Health Care | TRY 9.5B | TRY 354B | TRY 6,730.47 | 1.84% down | 7% down | ||
| 4 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 9.8B | TRY 629.6B | TRY 755.26 | 1.25% up | 5% up | ||
| 5 | Cogent BiosciencesCOGT · Health Care | TRY 11.2B | TRY 248.8B | TRY 1,429.82 | 1.80% up | 20% down | ||
| 6 | TG TherapeuticsTGTX · Health Care | TRY 12.4B | TRY 492B | TRY 3,255.29 | 2.93% up | 107% up | ||
| 7 | CytokineticsCYTK · Health Care | TRY 14.5B | TRY 359.4B | TRY 2,580.22 | 0.95% down | 20% down | ||
| 8 | Legend BiotechLEGN · Health Care | TRY 16.1B | TRY 158.9B | TRY 819.05 | 0.81% up | 42% down | ||
| 9 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 17.1B | TRY 480.1B | TRY 20,667.51 | 2.89% down | 24% down | ||
| 10 | InsmedINSM · Health Care | TRY 27.6B | TRY 1.33T | TRY 6,052.38 | 1.52% down | 40% down | ||
| 11 | Ascendis PharmaASND · Health Care | TRY 40.3B | TRY 892.4B | TRY 13,604.55 | 0.53% down | 28% up | ||
| 12 | BeOne MedicinesONC · Health Care | TRY 51.9B | TRY 2.32T | TRY 20,352.30 | 2.35% down | 17% up | ||
| 13 | Ionis PharmaceuticalsIONS · Health Care | TRY 91.4B | TRY 229.5B | TRY 1,378.12 | 1.35% up | 64% down | ||
| 14 | Regeneron PharmaceuticalsREGN · Health Care | TRY 100.2B | TRY 4.98T | TRY 48,131.57 | 0.36% down | 36% up | ||
| 15 | BridgeBio PharmaBBIO · Health Care | TRY 101.2B | TRY 762.3B | TRY 3,913.21 | 1.03% up | 17% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | TRY 129.7B | TRY 378.3B | TRY 1,085.85 | 1.94% up | 83% up | ||
| 17 | Elanco Animal HealthELAN · Health Care | TRY 202.6B | TRY 664.7B | TRY 1,329.96 | 2.01% up | 20% up | ||
| 18 | GenmabGMAB · Health Care | TRY 266B | TRY 1.6T | TRY 2,588.80 | 1.21% down | 70% up | ||
| 19 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 270.2B | TRY 788.4B | TRY 12,282.04 | 1.17% up | 37% up | ||
| 20 | Royalty PharmaRPRX · Health Care | TRY 451.4B | TRY 1.98T | TRY 3,451.73 | 0.35% down | 78% up | ||
| 21 | ZoetisZTS · Health Care | TRY 456B | TRY 1.72T | TRY 4,223.63 | 0.32% up | 29% down | ||
| 22 | Abbott LaboratoriesABT · Health Care | TRY 652.1B | TRY 9.1T | TRY 5,253.75 | 0.52% down | 17% down | ||
| 23 | ViatrisVTRS · Health Care | TRY 726.8B | TRY 1.19T | TRY 1,041.72 | 1.00% up | 96% up | ||
| 24 | GSKGSK · Health Care | TRY 967.5B | TRY 4.93T | TRY 2,459.69 | 0.95% down | 6% up | ||
| 25 | Novo NordiskNVO · Health Care | TRY 980.1B | TRY 8.82T | TRY 2,000.23 | 2.56% down | 17% down | ||
| 26 | SanofiSNY · Health Care | TRY 1.05T | TRY 5.73T | TRY 2,385.29 | 0.49% down | 4% down | ||
| 27 | NovartisNVS · Health Care | TRY 1.45T | TRY 14.87T | TRY 7,873.82 | 1.89% down | 25% up | ||
| 28 | AstraZenecaAZN · Health Care | TRY 1.49T | TRY 13.98T | TRY 9,012.38 | 1.96% down | 2% up | ||
| 29 | Takeda PharmaceuticalTAK · Health Care | TRY 1.54T | TRY 3.44T | TRY 1,077.28 | 1.29% down | 54% up | ||
| 30 | Eli LillyLLY · Health Care | TRY 2.14T | TRY 62.35T | TRY 69,995.38 | 1.96% down | 35% up | ||
| 31 | Bristol-Myers SquibbBMY · Health Care | TRY 2.28T | TRY 6.18T | TRY 3,024.05 | 2.27% down | 34% up | ||
| 32 | Johnson & JohnsonJNJ · Health Care | TRY 2.42T | TRY 33.41T | TRY 13,876.52 | 1.28% down | 38% up | ||
| 33 | Merck & CoMRK · Health Care | TRY 2.49T | TRY 17.34T | TRY 7,034.84 | 2.71% down | 51% up | ||
| 34 | PfizerPFE · Health Care | TRY 3.27T | TRY 8.09T | TRY 1,419.73 | 1.12% down | 14% up | ||
| 35 | AbbVieABBV · Health Care | TRY 3.4T | TRY 25.69T | TRY 14,535.70 | 1.57% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4344 TRY). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceuticals have the lowest total debt?
Definium Therapeutics (TRY 2B), Rhythm Pharmaceuticals (TRY 5.5B) and Axsome Therapeutics (TRY 9.5B) have the lowest total debt of the 35 pharmaceuticals ranked here as of 18 Nov 2026, 16:15 UTC.
How many pharmaceuticals are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 35 pharmaceuticals ranked by total debt have a combined market value of TRY 256.25T as of 18 Nov 2026, 16:15 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.